Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment

Joany Kreijne; Rozanne de Veer; NK de Boer; G Dijkstra; R West; SAW van Moorsel; DJ de Jong; C.J. van der Woude; Annemarie de Vries

doi:10.1111/apt.15402

Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment

Joany Kreijne, Rozanne de Veer, NK de Boer, G Dijkstra, R West, SAW van Moorsel, DJ de Jong, C.J. van der Woude, Annemarie de Vries

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	407-415
Number of pages	9
Journal	Alimentary Pharmacology & Therapeutics
Volume	50
Issue number	4
DOIs	https://doi.org/10.1111/apt.15402
Publication status	Published - 2019

Access to Document

10.1111/apt.15402

http://hdl.handle.net/1765/118548

Cite this

Kreijne, J., de Veer, R., de Boer, NK., Dijkstra, G., West, R., van Moorsel, SAW., de Jong, DJ., van der Woude, C. J., & de Vries, A. (2019). Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment. Alimentary Pharmacology & Therapeutics, 50(4), 407-415. https://doi.org/10.1111/apt.15402

@article{8f544460fce9414781a9344370fd0a97,

title = "Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment",

author = "Joany Kreijne and {de Veer}, Rozanne and {de Boer}, NK and G Dijkstra and R West and {van Moorsel}, SAW and {de Jong}, DJ and {van der Woude}, C.J. and {de Vries}, Annemarie",

year = "2019",

doi = "10.1111/apt.15402",

language = "Undefined/Unknown",

volume = "50",

pages = "407--415",

journal = "Alimentary Pharmacology & Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "4",

}

Kreijne, J , de Veer, R, de Boer, NK, Dijkstra, G, West, R, van Moorsel, SAW, de Jong, DJ, van der Woude, CJ & de Vries, A 2019, 'Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment', Alimentary Pharmacology & Therapeutics, vol. 50, no. 4, pp. 407-415. https://doi.org/10.1111/apt.15402

Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment. / Kreijne, Joany ; de Veer, Rozanne; de Boer, NK et al.
In: Alimentary Pharmacology & Therapeutics, Vol. 50, No. 4, 2019, p. 407-415.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment

AU - Kreijne, Joany

AU - de Veer, Rozanne

AU - de Boer, NK

AU - Dijkstra, G

AU - West, R

AU - van Moorsel, SAW

AU - de Jong, DJ

AU - van der Woude, C.J.

AU - de Vries, Annemarie

PY - 2019

Y1 - 2019

U2 - 10.1111/apt.15402

DO - 10.1111/apt.15402

M3 - Article

SN - 0269-2813

VL - 50

SP - 407

EP - 415

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

IS - 4

ER -